Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 15;2(4):280-291.
doi: 10.1530/RAF-20-0065. eCollection 2021 Dec.

Thyroid function and IVF outcome for different indications of subfertility

Affiliations

Thyroid function and IVF outcome for different indications of subfertility

C C Repelaer van Driel-Delprat et al. Reprod Fertil. .

Abstract

Abstract: Studies evaluating pregnancy outcomes after assisted reproductive treatment (ART) in women with high-normal (2.5-4.5 mIU/L) thyroid-stimulating hormone (TSH) levels are conflicting, possibly due to different patient charactistics and subfertility indications. The aim of this study was to examine the hypothesis that high-normal compared to low-normal TSH levels are associated with adverse implications for pregnancy outcomes in conventional in vitro fertilization (IVF)-treated women. Therefore, we analyzed retrospectively the characteristics and pregnancy outcomes of 949 subfertile women with TSH 0.3-4.5 mIU/L, treated with conventional IVF between January 2008 and March 2012. Demographic and baseline characteristics were compared between groups of patients based on TSH quartiles, using one-way Anova, Kruskal-Wallis ANOVA and chi-square test. Women with high-normal quartile TSH were significantly more likely to be primary subfertile (P = 0.01), with a higher prevalence of unexplained subfertility and with 15% fewer live births after IVF compared to lower TSH quartiles (P = 0.02). In secondary subfertile women with high-normal TSH, male factor subfertility prevailed (P = 0.01), with more live births (P = 0.01). When analyzing primary and secondary subfertile women as one group, these differences failed to be observed, showing no differences in cumulative pregnancy outcomes of IVF between TSH quartiles (I: 0.3-1.21 mIU/L; II: 1.22-1.68 mIU/L; III: 1.69-2.31 mIU/L; IV: 2.32-4.5 mIU/L). In conclusion, primary subfertile women predominate in the high-normal TSH quartile, associated with significantly fewer live births in a subgroup of primary unexplained subfertile women (9%; n = 87/949), while in secondary subfertile women, dominated by male factor subfertility, high-normal TSH is associated with more live births.

Lay summary: Thyroid hormones are required for all cell processes in the body. An underactive thyroid gland, in which insufficient thyroid hormones are produced and thyroid-stimulating hormone (TSH) rises, is associated with a lower chance of pregnancy. It is not yet clear above which TSH level, 4.5 or also 2.5 mIU/L, this lower probability occurs. Therefore, in 949 couples treated with conventional IVF, we examined whether high-normal TSH levels (TSH: 2.5-4.5 mIU/L) compared to low normal TSH levels (0.3-2.5 mIU/L) affect the live birth rate. We found that women who were trying to become pregnant for the first time, especially without any other cause, that is unexplained subfertility, were more likely to have higher TSH levels. These women had a much lower chance of having a baby compared to women with low-normal TSH levels.

Keywords: conventional in vitro fertilization; live birth rate; primary subfertility; thyroid-stimulating hormone; unexplained subfertility.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of TSH of 949 IVF treated women.

References

    1. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJet al.20172017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27315–389. (10.1089/thy.2016.0457) - DOI - PubMed
    1. Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of mbryology 2011. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Human Reproduction 261270–1283. - PubMed
    1. Andrisani A, Sabbadin C, Marin L, Ragazzi E, Dessole F, Armanini D, Dona G, Bordin L, Ambrosini G.2018The influence of thyroid autoimmunity on embryo quality in women undergoing assisted reproductive technology. Gynecological Endocrinology 34752–755. (10.1080/09513590.2018.1442427) - DOI - PubMed
    1. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, Livosli VA, Niccoli-Sire P, John R, Ruf Jet al.2003Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 133–126. (10.1089/105072503321086962) - DOI - PubMed
    1. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, van der Wal MF, Bonsel GJ.2007Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clinical Endocrinology 66765–770. (10.1111/j.1365-2265.2007.02803.x) - DOI - PubMed